ASX:EMR Emerald Resources (EMR) Stock Price, News & Analysis → Mysterious Gold Leverage Just Announced (From Stansberry Research) (Ad) Free EMR Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolume133,510 shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend Yield5.06%Price TargetN/A Stock AnalysisStock Analysis Get Emerald Resources alerts: Email Address Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> About Emerald Resources Stock (ASX:EMR)Emerald Resources NL engages in the exploration and development of mineral reserves in Cambodia and Australia. The company's exploration tenements include a combination of 100% owned granted licenses, applications, and earn-in and joint venture agreements covering a combined area of 1,239 square kilometers. Its principal property is the Okvau Gold project located in the city of Phnom Penh, province of Mondulkiri. The company was formerly known as Emerald Oil & Gas NL and changed its name to Emerald Resources NL in December 2014. The company was incorporated in 1969 and is headquartered in West Perth, Australia.Read More Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> EMR Stock News HeadlinesApril 9, 2024 | finance.yahoo.comAre Strong Financial Prospects The Force That Is Driving The Momentum In Emerald Resources NL's ASX:EMR) Stock?March 23, 2024 | finance.yahoo.comThose who invested in Emerald Resources (ASX:EMR) five years ago are up 562%April 25, 2024 | Behind the Markets (Ad)Better than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.March 2, 2024 | finance.yahoo.comEmerald Resources First Half 2024 Earnings: Beats ExpectationsFebruary 28, 2024 | health.usnews.comSenior Living Communities Near Emerald Bay, TXJanuary 31, 2024 | finance.yahoo.comHere's Why We Think Emerald Resources (ASX:EMR) Is Well Worth WatchingJanuary 3, 2024 | morningstar.comEmerald Resources NL EMRDecember 16, 2023 | finance.yahoo.comEmerald Resources NL (ASX:EMR) surges 11%; individual investors who own 39% shares profited along with institutionsApril 25, 2024 | Behind the Markets (Ad)Better than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.November 22, 2023 | finance.yahoo.comIt Looks Like The CEO Of Emerald Resources NL (ASX:EMR) May Be Underpaid Compared To PeersOctober 31, 2023 | msn.comGround Breakers: Emerald as good as gold as Cambodian miner marches into ASX 200October 9, 2023 | finance.yahoo.comEmerald Resources (ASX:EMR) pulls back 6.7% this week, but still delivers shareholders fantastic 50% CAGR over 5 yearsSeptember 20, 2023 | msn.comMonsters of Rock: Emerald yet to hit the BullseyeSeptember 1, 2023 | finance.yahoo.comEmerald Resources Full Year 2023 Earnings: EPS Beats ExpectationsSeptember 1, 2023 | msn.comGround Breakers: Some late, breaking dividends for FY23 and a week from hell for Andrew ForrestAugust 24, 2023 | finance.yahoo.comDoes Emerald Resources (ASX:EMR) Deserve A Spot On Your Watchlist?August 10, 2023 | technews.tmcnet.comGrizzly Emerald Auction Generates Record US$48.63 millionJuly 8, 2023 | finance.yahoo.comWhile institutions own 32% of Emerald Resources NL (ASX:EMR), individual investors are its largest shareholders with 40% ownershipMay 24, 2023 | finance.yahoo.comIs Emerald Resources NL's (ASX:EMR) Recent Stock Performance Tethered To Its Strong Fundamentals?April 28, 2023 | marketwatch.comDentistry EMR Software Market Size by 2031April 28, 2023 | marketwatch.comAmbulatory EHR & EMR Systems Market Complete Overview till 2031April 7, 2023 | finance.yahoo.comEmerald Resources (ASX:EMR) shareholders have earned a 35% CAGR over the last five yearsMarch 17, 2023 | finance.yahoo.comShould You Be Adding Emerald Resources (ASX:EMR) To Your Watchlist Today?February 13, 2023 | msn.comResources Top 5: Chalice spinout hits paydirt in region with 32Moz of undiscovered goldJanuary 29, 2023 | finance.yahoo.comWhile institutions own 28% of Emerald Resources NL (ASX:EMR), individual investors are its largest shareholders with 51% ownershipDecember 15, 2022 | finance.yahoo.comIs Emerald Resources NL's (ASX:EMR) Latest Stock Performance Being Led By Its Strong Fundamentals?November 18, 2022 | finance.yahoo.comHere's Why Emerald Resources NL's (ASX:EMR) CEO May Deserve A RaiseSee More Headlines Receive EMR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Emerald Resources and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/16/2018Today4/25/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeASX SectorBasic Materials Industry Gold Sub-IndustryN/A Current SymbolASX:EMR CUSIPN/A CIKN/A Webemeraldresources.com.au Phone+61-3-00729543FaxN/AEmployees280Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)A$0.14 Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$92.14 million Net Margins26.76% Pretax MarginN/A Return on Equity24.45% Return on Assets17.17% Debt Debt-to-Equity Ratio21.18 Current Ratio1.42 Quick Ratio0.66 Sales & Book Value Annual Sales$344.31 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow14.00 Book ValueA$0.68 per share Price / BookN/AMiscellaneous Outstanding Shares625,880,000Free FloatN/AMarket CapN/A OptionableNot Optionable Beta1.08 These 7 Stocks Will Be Magnificent in 2024With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.Get This Free Report Key ExecutivesMr. Morgan Cain Hart (Age 56)MD & Executive Director Comp: $661.51kMs. Shannon CampbellChief Financial OfficerMr. Michael EvansExecutive DirectorMr. Mark Andrew Clements B.ComB.Com., F.C.A., FCA, M.A.I.C.D., MAICD, Company SecretaryMr. Bernie ClearyOperations ManagerKey CompetitorsAben MineralsOTCMKTS:ABNAFAdelong GoldASX:ADGAlacer GoldOTCMKTS:ALIAFALACERGOLD/IDR UNRESTRASX:AQGAlchemy ResourcesASX:ALYView All CompetitorsInsidersMichael (Mick) EvansSold 500,000 sharesTotal: $1.39 M ($2.77/share)Michael (Mick) EvansSold 500,000 sharesTotal: $995,000.00 ($1.99/share) EMR Stock Analysis - Frequently Asked Questions How were Emerald Resources' earnings last quarter? Emerald Resources NL (ASX:EMR) issued its earnings results on Friday, March, 16th. The company reported $0.00 earnings per share (EPS) for the quarter. Emerald Resources had a trailing twelve-month return on equity of 24.45% and a net margin of 26.76%. What other stocks do shareholders of Emerald Resources own? Based on aggregate information from My MarketBeat watchlists, some companies that other Emerald Resources investors own include PepsiCo (PEP), Basf (BAS), GAP (GPS), Johnson & Johnson (JNJ), Robert Half (RHI), Corium International (CORI), Fate Therapeutics (FATE), CarMax (KMX), Parsley Energy (PE) and Rapid7 (RPD). This page (ASX:EMR) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsJim Cramer’s “The Biggest Drug Ever”Behind the MarketsYour Money is Not SafeAmerican AlternativeThe AI stock to buy right nowStockEarningsThe only accurate crypto trading system I know …Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Emerald Resources NL Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
